{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:56:25Z","timestamp":1792842985451,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Science and Technology Research Foundation of Guangdong Province","award":["No. A2022454"],"award-info":[{"award-number":["No. A2022454"]}]},{"name":"National Natural Science Foundation Incubation Project of The Third Affiliated Hospital of Sun Yat-sen University","award":["No. 2021GZRPYQN09"],"award-info":[{"award-number":["No. 2021GZRPYQN09"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 91859115"],"award-info":[{"award-number":["No. 91859115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The current diagnostic methods of microinvasive cervical cancer lesions are imaging diagnosis and pathological evaluation. Pathological evaluation is invasive and imaging approaches are of extremely low diagnostic performance. There is a paucity of effective and noninvasive imaging approaches for these extremely early cervical cancer during clinical practice. In recent years, ultrasound molecular imaging (USMI) with vascular endothelial growth factor receptor type 2 (VEGFR2) targeted microbubble (MB<jats:sub>VEGFR2<\/jats:sub>) has been reported to improve the early diagnosis rates of breast cancer (including ductal carcinoma in situ), pancreatic cancer and hepatic micrometastases. Herein, we aimed to assess the feasibility of MB<jats:sub>VEGFR2<\/jats:sub>-based USMI in extremely early cervical cancer detection to provide an accurate imaging modality for microinvasive cervical cancer (International Federation of Gynecology and Obstetrics (FIGO) Stage IA1 and IA2).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found MB<jats:sub>VEGFR2<\/jats:sub>-based USMI could successfully distinguish extremely early lesions in diameter\u2009&lt;\u20093\u00a0mm from surrounding normal tissues (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), and the sensitivity gradually decreased along with increasing tumor diameter. Moreover, normalized intensity difference (NID) values showed a good linear correlation with microvessel density (MVD) (R<jats:sup>2<\/jats:sup>\u2009=\u20090.75). In addition, all tumors could not be identified from surrounding muscles in subtracted ultrasound images when mice were administered MB<jats:sub>Con<\/jats:sub>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Overall, MB<jats:sub>VEGFR2<\/jats:sub>-based USMI has huge potential for clinical application for the early detection of microinvasive cervical cancer (FIGO Stage IA1 and IA2), providing the foothold for future studies on the imaging screening of this patient population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12951-023-01984-2","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T07:02:13Z","timestamp":1689145333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["VEGFR2 targeted microbubble-based ultrasound molecular imaging improving the diagnostic sensitivity of microinvasive cervical cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Junlin","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manting","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoshan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"1984_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"1984_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ogc.2012.02.008","volume":"39","author":"JS Lea","year":"2012","unstructured":"Lea JS, Lin KY. Cervical cancer. Obstet Gynecol Clin North Am. 2012;39:233\u2013253.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"1984_CR3","doi-asserted-by":"crossref","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018; 143 Suppl2: 22\u201336.","DOI":"10.1002\/ijgo.12611"},{"key":"1984_CR4","doi-asserted-by":"crossref","unstructured":"Roh JW, Lee DO, Suh DH, et al. Efficacy and oncologic safety of nerve - sparing radical hysterectomy for cervical cancer: A randomized controlled trial. J Gynecol Oncol.2015; 26:90\u201399.","DOI":"10.3802\/jgo.2015.26.2.90"},{"key":"1984_CR5","doi-asserted-by":"crossref","unstructured":"Rombouts AJM, Hugen N, van Beek JJP, et al. Does pelvic radiation increase rectal cancer incidence? - A systematic review and meta-analysis. Cancer Treat Rev. 2018; 68:136\u2013144.","DOI":"10.1016\/j.ctrv.2018.05.008"},{"key":"1984_CR6","doi-asserted-by":"crossref","unstructured":"Taarnh\u00f8j GA, Christensen IJ, Lajer H, et al. Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005\u20132013: A national cohort study.Cancer. 2018; 124(5):943\u2013951.","DOI":"10.1002\/cncr.31165"},{"key":"1984_CR7","doi-asserted-by":"crossref","unstructured":"Lee SW, Kim YM, Son WS, et al. The efficacy of conservative management after conization in patients with stage IA1 microinvasive cervical carcinoma. Acta Obstet Gynecol Scand.2009; 88: 209\u2013215.","DOI":"10.1080\/00016340802596009"},{"key":"1984_CR8","doi-asserted-by":"crossref","unstructured":"Bouchard-Fortier G, Reade CJ, Covens A. Non- radical surgery for small early-stage cervical cancer. Is it time? Gynecol Oncol. 2014; 132:624\u2013627.","DOI":"10.1016\/j.ygyno.2014.01.037"},{"key":"1984_CR9","doi-asserted-by":"crossref","unstructured":"Kato T, T akashima A, Kasamatsu T, et al. Gynecologic Oncology Study Group of the Japan Clinical Oncology Group. Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A). Gynecol Oncol. 2015; 137: 34\u201339.","DOI":"10.1016\/j.ygyno.2015.01.548"},{"key":"1984_CR10","doi-asserted-by":"crossref","unstructured":"Shepherd JH, Spencer C, Herod J, Ind TE. Radical vaginal trachelectomy as a fertility-sparing procedure in women with early- stage cervical cancer-cumulative pregnancy rate in a series of 123 women. BJOG. 2006; 113: 719\u2013724.","DOI":"10.1111\/j.1471-0528.2006.00936.x"},{"key":"1984_CR11","doi-asserted-by":"crossref","unstructured":"Salvo G, Odetto D, Saez Perrotta MC, et al. Measurement of tumor size in early cervical cancer: an ever-evolving paradigm. Int J Gynecol Cancer. 2020; 30(8):1215\u20131223.","DOI":"10.1136\/ijgc-2020-001436"},{"key":"1984_CR12","doi-asserted-by":"crossref","unstructured":"Lee SI, Atri M. 2018 FIGO Staging System for Uterine Cervical Cancer: Enter Cross-sectional Imaging. Radiology. 2019; 292(1):15\u201324.","DOI":"10.1148\/radiol.2019190088"},{"key":"1984_CR13","doi-asserted-by":"crossref","unstructured":"Fischerova D, Cibula D, Stenhova H, et al. Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer. Int J Gynecol Cancer. 2008;18:766\u2013772.","DOI":"10.1111\/j.1525-1438.2007.01072.x"},{"key":"1984_CR14","doi-asserted-by":"crossref","unstructured":"Epstein E, Testa A, Gaurilcikas A, et al. Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound- a European multicenter trial. Gynecol Oncol. 2013; 128(3):449\u2013453.","DOI":"10.1016\/j.ygyno.2012.09.025"},{"key":"1984_CR15","doi-asserted-by":"crossref","unstructured":"Zheng W, Xiong YH, Han J, et al. Contrast-enhanced ultrasonography of cervical carcinoma: perfusion pattern and relationship with tumour angiogenesis. Br J Radiol.2016; 89(1065):20150887.","DOI":"10.1259\/bjr.20150887"},{"key":"1984_CR16","doi-asserted-by":"crossref","unstructured":"Zheng W, Chen K, Peng C, et al. Contrast-enhanced ultrasonography vs MRI for evaluation of local invasion by cervical cancer. Br J Radiol. 2018; 91(1091):20170858.","DOI":"10.1259\/bjr.20170858"},{"key":"1984_CR17","doi-asserted-by":"crossref","unstructured":"K\u00f6se G, Darguzyte M, Kiessling F. Molecular Ultrasound Imaging. Nanomaterials(Basel). 2020; 10(10):1935.","DOI":"10.3390\/nano10101935"},{"key":"1984_CR18","doi-asserted-by":"crossref","unstructured":"Lassau N, Lamuraglia M, Chami L, et al. Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. AJR Am J Roentgenol.2006; 187(5):1267\u20131273.","DOI":"10.2214\/AJR.05.1192"},{"key":"1984_CR19","doi-asserted-by":"crossref","unstructured":"P\u00e1lsd\u00f3ttir K, Epstein E. A Pilot Study on Diagnostic Performance of Contrast-Enhanced Ultrasonography for Detection of Early Cervical Cancer. Ultrasound Med Biol. 2018; 44(8):1664\u20131671.","DOI":"10.1016\/j.ultrasmedbio.2018.04.018"},{"key":"1984_CR20","doi-asserted-by":"crossref","unstructured":"Green RW, Epstein E. Dynamic contrast-enhanced ultrasound improves diagnostic performance in endometrial cancer staging. Ultrasound Obstet Gynecol. 2020; 56(1):96\u2013105.","DOI":"10.1002\/uog.21885"},{"key":"1984_CR21","doi-asserted-by":"crossref","unstructured":"deSouza NM, Dina R, McIndoe GA, et al. Cervical cancer: value of an endovaginal coil magnetic resonance imaging technique in detecting small volume disease and assessing parametrial extension. Gynecol Oncol. 2006;102(1):80\u201385.","DOI":"10.1016\/j.ygyno.2005.11.038"},{"key":"1984_CR22","doi-asserted-by":"crossref","unstructured":"Ozsarlak O, Tjalma W, Schepens E, et al. The correlation of preoperative CT, MR imaging,and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma.Eur Radiol. 2003;13(10):2338\u20132345.","DOI":"10.1007\/s00330-003-1928-2"},{"key":"1984_CR23","doi-asserted-by":"crossref","unstructured":"Hori M, Kim T, Murakami T, et al. Uterine cervical carcinoma: preoperative staging with 3.0-T MR imaging\u2013comparison with 1.5-T MR imaging. Radiology. 2009; 251(1):96\u2013104.","DOI":"10.1148\/radiol.2511081265"},{"key":"1984_CR24","doi-asserted-by":"crossref","unstructured":"Lindner JR. Molecular imaging of myocardial and vascular disorders with ultrasound.JACC Cardiovasc Imaging. 2010; 3(2):204\u2013211.","DOI":"10.1016\/j.jcmg.2009.09.021"},{"key":"1984_CR25","doi-asserted-by":"crossref","unstructured":"Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 2011; 10(6):417\u2013427.","DOI":"10.1038\/nrd3455"},{"key":"1984_CR26","doi-asserted-by":"crossref","unstructured":"Ribatti D, Pezzella F. Overview on the Different Patterns of Tumor Vascularization.Cells. 2021;10(3):639.","DOI":"10.3390\/cells10030639"},{"key":"1984_CR27","doi-asserted-by":"crossref","unstructured":"Claesson-Welsh L, Welsh M. VEGFA and tumour angiogenesis. J Intern Med. 2013; 273(2):114\u2013127.","DOI":"10.1111\/joim.12019"},{"key":"1984_CR28","doi-asserted-by":"crossref","unstructured":"Han Q, Jia X, Qian Y, et al. Peptide functionalized targeting liposomes: for nanoscale drug delivery towards angiogenesis. J Mater Chem B. 2016;4(44):7087\u20137091.","DOI":"10.1039\/C6TB01823H"},{"key":"1984_CR29","doi-asserted-by":"crossref","unstructured":"Pysz MA, Machtaler SB, Seeley ES, et al. Vascular endothelial growth factor receptor type 2 targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: Potential for earlier detection. Radiology. 2015; 274(3):790\u2013799.","DOI":"10.1148\/radiol.14140568"},{"key":"1984_CR30","doi-asserted-by":"crossref","unstructured":"Bachawal SV, Jensen KC, Lutz AM, et al. Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model. Cancer Res. 2013; 73(6):1689\u20131698.","DOI":"10.1158\/0008-5472.CAN-12-3391"},{"key":"1984_CR31","doi-asserted-by":"crossref","unstructured":"Bzyl J, Palmowski M, Rix A, et al. The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55). Eur Radiol. 2013; 23(2):468\u2013475.","DOI":"10.1007\/s00330-012-2594-z"},{"key":"1984_CR32","doi-asserted-by":"crossref","unstructured":"Hackl C, Schacherer D, Anders M, et al. Improved Detection of preclinical Colorectal Liver Metastases by High Resolution Ultrasound including Molecular Ultrasound Imaging using the targeted Contrast Agent BR55. Ultraschall Med. 2016; 37(3):290\u2013296.","DOI":"10.1055\/s-0041-111838"},{"key":"1984_CR33","doi-asserted-by":"crossref","unstructured":"Balleyguier C, Sala E, Da Cunha T, et al. Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur Radiol. 2011;21:1102\u20131110.","DOI":"10.1007\/s00330-010-1998-x"},{"key":"1984_CR34","doi-asserted-by":"crossref","unstructured":"Hsiao YH, Yang SF, Chen YH, et al. Updated applications of Ultrasound in Uterine Cervical Cancer. J Cancer. 2021; 12(8):2181\u20132189.","DOI":"10.7150\/jca.49479"},{"key":"1984_CR35","doi-asserted-by":"crossref","unstructured":"Salvo G, Odetto D, Saez Perrotta MC, et al. Measurement of tumor size in early cervical cancer: an ever-evolving paradigm. Int J Gynecol Cancer. 2020; 30(8):1215\u20131223.","DOI":"10.1136\/ijgc-2020-001436"},{"key":"1984_CR36","doi-asserted-by":"crossref","unstructured":"Willmann JK, Bonomo L, Testa AC, et al. Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results. J Clin Oncol. 2017; 35(19):2133\u20132140.","DOI":"10.1200\/JCO.2016.70.8594"},{"key":"1984_CR37","doi-asserted-by":"crossref","unstructured":"Smeenge M, Tranquart F, Mannaerts CK, et al. First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot Study. Invest Radiol. 2017; 52(7):419\u2013427.","DOI":"10.1097\/RLI.0000000000000362"},{"key":"1984_CR38","doi-asserted-by":"crossref","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646\u2013674.","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"1984_CR39","doi-asserted-by":"crossref","unstructured":"Vajkoczy P, Farhadi M, Gaumann A, et al. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. Clin Invest.2002; 109(6):777\u2013785.","DOI":"10.1172\/JCI0214105"},{"key":"1984_CR40","doi-asserted-by":"crossref","unstructured":"Marshall D, Pedley RB, Boden JA, et al. Polyethylene glycol modification of a galactosylated streptavidin clearing agent: Effects on immunogenicity and clearance of a biotinylated anti-tumour antibody. Br J Cancer. 1996; 73(5):565\u2013572.","DOI":"10.1038\/bjc.1996.99"},{"key":"1984_CR41","doi-asserted-by":"crossref","unstructured":"Meyer DL, Schultz J, Lin Y, et al. Reduced antibody response to streptavidin through site-directed mutagenesis. Protein Sci. 2001; 10(3):491\u2013503.","DOI":"10.1110\/ps.19901"},{"key":"1984_CR42","doi-asserted-by":"crossref","unstructured":"Qian Y, Wang W, Wang Z, Han Q, Jia X, Yang S, Hu Z. Switchable probes: pH-triggered and VEGFR2 targeted peptides screening through imprinting microarray. Chem Commun (Camb). 2016; 52(33):5690\u20135693.","DOI":"10.1039\/C6CC01302C"},{"key":"1984_CR43","doi-asserted-by":"crossref","unstructured":"Han Q, Jia X, Qian Y, Wang Z, Yang S, Jia Y, Wang W, Hu Z. Peptide functionalized targeting liposomes: for nanoscale drug delivery towards angiogenesis. J Mater Chem B. 2016; 4(44):7087\u20137091.","DOI":"10.1039\/C6TB01823H"},{"key":"1984_CR44","doi-asserted-by":"crossref","unstructured":"Zhai Y, Petrowsky H, Hong JC, et al. Ischaemia-reperfusion injury in liver transplantation-from bench to bedside. Nat Rev Gastroenterol Hepatol. 2013; 10(2): 79\u201389.","DOI":"10.1038\/nrgastro.2012.225"},{"key":"1984_CR45","doi-asserted-by":"crossref","unstructured":"Gao Y, Zheng QC, Xu S, et al. Theranostic Nanodots with Aggregation-Induced Emission Characteristic for Targeted and Image-Guided Photodynamic Therapy of Hepatocellular Carcinoma. Theranostics. 2019; 9(5):1264\u20131279.","DOI":"10.7150\/thno.29101"},{"key":"1984_CR46","doi-asserted-by":"crossref","unstructured":"Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst. 1992; 84(24):1875\u20131887.","DOI":"10.1093\/jnci\/84.24.1875"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01984-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-01984-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01984-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T07:04:22Z","timestamp":1689145462000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-01984-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1984"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-01984-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"assertion":[{"value":"8 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}